CAS 843782-19-4 Niraparib Tosylate – High‑Purity API for Oncology Trials
Your Fast, Cost‑Effective Source for Clinical‑Grade Supply
Designed for pharmaceutical R&D, CROs, and global manufacturers who demand consistent quality, on‑time delivery, and transparent pricing.
Get Free Quote in 24 HoursThe Real‑World Challenges Holding Your Oncology Programs Back
As a Purchasing Manager or Technical Director, you constantly juggle cost pressure, quality compliance, and supply reliability. Below are the three most common pain points we hear from executives like you:
- 1. Sky‑High API Prices: Traditional suppliers quote a 30‑45% premium for GMP‑grade Niraparib Tosylate, inflating trial budgets.
- 2. Uncertain Purity & Batch‑to‑Batch Consistency: Inconsistent HPLC profiles force re‑validation, delaying IND submissions.
- 3. Slow Lead Times & Expensive Freight: Average delivery from Europe exceeds 45 days with shipping costs that erode margins.
Data point: A 2025 survey of 112 US biotech firms showed that 58% postponed Phase II studies because of API supply bottlenecks. Imagine the opportunity cost of a delayed trial.
Why Global Technology Co., Ltd. Is the Answer to Your API Needs
Our CAS 843782-19-4 Niraparib Tosylate is produced in a GMP‑certified facility with a purity ≥ 99.5 %. We combine a vertically integrated supply chain with AI‑driven batch monitoring to guarantee on‑time, cost‑effective deliveries.
Core Advantages (3‑6 Points)
- Price Advantage: Up to 30 % lower than European competitors, thanks to our Chinese manufacturing hub and bulk‑order discounts.
- Quality Assurance: Certified by ISO 9001, GMP, FDA‑registered, and DMF‑approved. Full analytical package includes HPLC, NMR, MS, and residual solvent testing.
- Fast Delivery: Standard 15‑day production + 3‑day logistics to the US West Coast; Express Air option within 7 days.
- OEM/ODM Flexibility: Custom packaging (bulk, vial, ampoule) and label design available to match your trial protocol.
- Regulatory Support: We provide ready‑to‑file documentation (COA, Certificate of Origin, SDS) for IND, NDA, and GMP audits.
Technical Specification Table
| Parameter | Specification | Method |
|---|---|---|
| CAS No. | 843782‑19‑4 | — |
| Chemical Name | Niraparib Tosylate | — |
| Purity | ≥ 99.5 % (HPLC) | HPLC (UV 254 nm) |
| Appearance | White to off‑white crystalline powder | Visual inspection |
| Molecular Formula | C19H19FN5O3S·C2H6O2S | — |
| Molecular Weight | 433.46 g mol⁻¹ (free base) / 534.60 g mol⁻¹ (tosylate) | — |
| Solubility | 0.5 mg mL⁻¹ in water (pH 7), soluble in DMSO, DMF | Shake‑flask |
| Stability | Stable 24 months at 25 °C (dry, protected from light) | ICH‑Q1A(R2) |
| Packaging | 25 g, 100 g, 500 g, 1 kg HDPE jars; optional nitrogen‑purged vacuum sealed | — |
| Regulatory Docs | COA, SDS, DMF, Certificate of Analysis, GMP Audit Report | — |
Application Scenarios & Case Studies
Case 1 – Phase I Oncology Trial (USA): A mid‑size biotech required 2 kg of Niraparib Tosylate for a first‑in‑human study. We delivered 2 kg within 18 days, saving the client USD 12,500 in freight and enabling a 10‑day earlier IND filing.
Case 2 – GMP Manufacturing (EU): A contract manufacturing organization (CMO) needed a consistent batch size of 5 kg for a GMP‑scale production run. Our real‑time batch analytics ensured ±0.2 % impurity variation across 3 consecutive batches, meeting EMA specifications without additional re‑testing.
Case 3 – Custom Formulation (Asia Pacific): An oncology‑focused CRO requested 250 g of Niraparib Tosylate pre‑filled in 10 mL sterile vials. We provided a turnkey solution – analytical package, sterile filtration, and labeling – reducing their internal handling time by 45 %.
Antiviral-drug-discovery-peptide-development-service 5-Demethylnobiletin-powder-supplier 10-hydroxydecanoic-acid-CAS-1679-53-4 CAS-147732-56-7-Bivalirudin-Acetate
Start your own success story today.Frequently Asked Questions
What is the minimum order quantity (MOQ) for CAS 843782‑19‑4 Niraparib Tosylate?
We accept orders as low as 100 g for research use and 5 kg for GMP manufacturing. Larger volumes receive tiered discounts.
Can you provide a custom batch record or DMF for regulatory filing?
Yes. Our Quality Assurance team can issue a **DMF‑type documentation package**, including batch records, analytical methods, and stability data, fully compliant with FDA and EMA requirements.
What are the payment terms for first‑time buyers?
Standard terms are **T/T 30 % deposit, 70 % against copy of B/L**. For verified corporate accounts we can offer **Net 30** after the first successful shipment.
How do you ensure the product meets USP‑NF or EP standards?
Our manufacturing follows **USP <1065>** and **EP <2.2.1>** guidelines. Every batch undergoes HPLC, NMR, and mass‑spectrometry verification, and the full analytical report is attached to the COA.
What logistics options are available for urgent shipments?
We partner with DHL, FedEx, and UPS for **express air** (2‑5 days) and **temperature‑controlled** options. For bulk orders, we offer **FCL/LCL sea freight** with real‑time tracking.
Do you provide after‑sales technical support?
Absolutely. Our R&D scientists are on‑call 24 hours for analytical queries, formulation advice, and stability study design.
Ready to Accelerate Your Clinical Program?
Limited‑time offer: **Free 5 g sample** (no charge, no obligation) for verified corporate accounts. Only 50 samples left for Q3 2026.
Request Sample Contact Sales (WhatsApp/WeChat)*All shipments comply with local export regulations and include full documentation for customs clearance.
Real Feedback from Global Buyers
-
Michael O'Connor, Procurement Manager, NovaPharm USA – “The **cost reduction** of 28 % versus our previous supplier allowed us to re‑allocate budget to additional pre‑clinical studies. Delivery was exactly as promised.”
-
Dr. Sarah Liu, CTO, OncoGenics Ltd. – “Analytical data were **clear and reproducible**. The OEM vial packaging saved us weeks of sterile‑filtration work.”
-
Ravi Kumar, Operations Lead, BioBridge India – “Fast customs clearance thanks to the complete **SDS/COA package**. We received the product in 12 days total.”
About the Author
Dr. Victor Huang, Ph.D. – Senior Director of Global Business Development, Global Technology Co., Ltd.
With **15 years** of experience in API manufacturing, GMP compliance, and cross‑border supply chain optimization, Dr. Huang has led projects supplying over **10 tonnes** of oncology APIs to the US, EU, and Asia‑Pacific markets. He holds an MBA from INSEAD and regularly contributes to Pharma Manufacturing Today.
Contact: service@huanqiukeji9.com | Phone: +86 199 4383 0844
Trusted by Leading Pharma & Biotech Brands
What Our Clients Say
Certificates & Compliance